ImmunoGen, Inc. to Ring the NASDAQ Stock Market Closing Bell

ADVISORY, April 1, 2013 (GLOBE NEWSWIRE) --

What:

ImmunoGen, Inc. [IMGN], a developer of targeted anticancer therapeutics, will visit the NASDAQ MarketSite in Times Square.

In honor of the occasion, Daniel Junius, President and CEO, will ring the Closing Bell.

Where:

NASDAQ MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

MORE ON THIS TOPIC